tubulin beta 8 class VIII pseudogene 7Genealiases: []
Q-omics provides the consensus-scored TUBB8P7 profile across patient tissues and cancer cell-line models. TUBB8P7 expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, TUBB8P7 is differentially expressed in 12, with the highest sampling consensus in KIRP. Additionally, TUBB8P7 RNA expression shows 16,118 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight ACC, KIRP, and THYM as cancer lineages where TUBB8P7 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for TUBB8P7 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes TUBB8P7 survival associations across molecular data types. TUBB8P7 RNA expression shows survival associations in the most cancer types (21), followed by mutation status (5). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible TUBB8P7 RNA expression–survival associations across cancer types. High TUBB8P7 expression shows unfavorable associations in ACC, LGG, STAD and GBM, but favorable associations in HNSC and SKCM. The ACC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for TUBB8P7 RNA expression.
This table summarizes TUBB8P7 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 12. The strongest signals are observed in KIRP for RNA.
This table ranks reproducible tumor–normal expression differences for TUBB8P7. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. TUBB8P7 shows lower tumor expression in KIRP, KICH and KIRC and higher tumor expression in CHOL, HNSC and UCEC. The KIRP box plot shows higher TUBB8P7 RNA expression in normal versus tumor tissue (log2 FC = −1.054, t-test p < 0.001).
This table shows molecular features associated with TUBB8P7 in patient tissues and cancer cell lines. In patient samples, TUBB8P7 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
